Tokyo-based Takeda Pharmaceutical has agreed to pay $1.85 million as a settlement with consumers who filed a lawsuit against the company for allegedly delaying the commercial release of a generic, cheaper version of its ADHD drug.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,